在严重的COVID-19感染后1年内,尽管有持续的肺纤维化,但肺功能和运动耐受性得到改善
Claire F McGroder1, Mary M Salvatore2, Belinda M D'Souza2
1Medicine/Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Thorax
|March 21, 2024
概括
严重的COVID-19幸存者在住院15个月后,肺纤维化改善,并恶化了网膜. 像呼吸障碍这样的持续症状表明非呼吸道原因,需要持续监测肺部异常.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 放射学 放射学是一门学科.
背景情况:
- 严重的COVID-19可能导致长期的呼吸道并发症.
- 了解肺部异常和持续症状的进展对于患者的康复至关重要.
研究的目的:
- 在严重的COVID-19幸存者中评估长期肺和非肺结局.
- 在住院15个月后,调查放射检测结果与临床症状之间的关系.
主要方法:
- 对104名严重COVID-19幸存者的前性单中心队列研究.
- 在4个月和15个月的评估包括肺功能测试,6分钟的步行距离,握力,脆弱性评估和症状评估.
- 分析了放射性成像 (地面玻璃不透明度,纤维状网膜).
主要成果:
- 64%的幸存者在胸部成像上表现出纤维化模式.
- 肺功能,握力,6分钟的步行距离和脆弱性在15个月后正常化.
- 磨砂玻璃不透明度的改善与纤维状网络的恶化相关.
- 呼吸不全,咳和疲劳持续存在,与肺功能或放射性纤维化无关.
结论:
- 尽管有放射性纤维化,但在严重的COVID-19幸存者中,关键的生理措施正常化.
- 持续的症状表明非呼吸系统因素有助于长期的发病率.
- 长期监测间歇性肺异常是必要的,以预测未来的进展.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
269
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
269
COPD: Management Using Bronchodilators and Corticosteroids
202
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
202
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


